| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.13B | 96.36B | 73.02B | 49.60B | 31.90B | 30.36B |
| Gross Profit | 22.16B | 21.11B | 15.41B | 10.37B | 7.66B | 7.13B |
| EBITDA | 18.51B | 17.03B | 10.96B | 6.74B | 4.61B | 3.75B |
| Net Income | 10.25B | 10.20B | 7.98B | 5.81B | 3.29B | 2.62B |
Balance Sheet | ||||||
| Total Assets | 103.87B | 116.78B | 70.60B | 41.92B | 27.24B | 24.92B |
| Cash, Cash Equivalents and Short-Term Investments | 18.89B | 17.33B | 12.14B | 14.12B | 10.08B | 9.86B |
| Total Debt | 47.98B | 53.20B | 22.40B | 3.47B | 2.69B | 2.63B |
| Total Liabilities | 68.92B | 79.77B | 41.68B | 20.52B | 11.31B | 11.73B |
| Stockholders Equity | 34.95B | 37.01B | 28.92B | 21.40B | 15.93B | 13.19B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -22.31B | -19.01B | 3.66B | 954.82M | 5.80B |
| Operating Cash Flow | 0.00 | -20.20B | -18.66B | 4.68B | 1.13B | 5.96B |
| Investing Cash Flow | 0.00 | -2.74B | 386.99M | 64.81M | 134.01M | -433.48M |
| Financing Cash Flow | 0.00 | 27.18B | 17.45B | -24.90M | -881.82M | -937.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥59.91B | 10.64 | ― | 2.79% | 2.85% | 3.17% | |
75 Outperform | ¥65.86B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
73 Outperform | ¥136.04B | 19.55 | ― | 2.86% | 89.90% | 190.48% | |
70 Outperform | ¥166.55B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
70 Outperform | ¥88.33B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥10.27B | 42.22 | ― | 1.65% | 3.96% | ― |